Efficacy and safety of pimecrolimus cream 1% in infants: A combined analysis of a clinical program in 923 patients

被引：0
|
作者：
Paul, C
Rossi, AB
Cork, M
de Prost, Y
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England
[3] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[4] Hop Necker Enfants Malad, Paris, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P69 / P69
页数：1
相关论文
共 50 条
  • [31] An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba
    Fujita, Wayne H.
    McCormick, Calogera L.
    Parneix-Spake, Anne
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (07) : 700 - 705
  • [32] Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis
    Breuer, K
    Braeutigam, M
    Kapp, A
    Werfel, T
    DERMATOLOGY, 2004, 209 (04) : 314 - 320
  • [33] Subgroup analysis of elderly patients in a study of pimecrolimus cream 1% for treatment of seborrheic dermatitis.
    Warshaw, E
    Wohlhuter, J
    Drake, D
    Liu, A
    Zeller, S
    Wenner, R
    Bowers, S
    Schultz, J
    Geba, GP
    Katz, HI
    Parneix-Spake, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S26 - S26
  • [34] Efficacy and Safety of Pimecrolimus Cream 1% in Mild-to-Moderate Chronic Hand Dermatitis: A Randomized, Double-Blind Trial
    Hordinsky, Maria
    Fleischer, Alan
    Rivers, Jason K.
    Poulin, Yves
    Belsito, Donald
    Hultsch, Thomas
    DERMATOLOGY, 2010, 221 (01) : 71 - 77
  • [35] Pimecrolimus cream 1% provides effective long-term control of atopic dermatitis in infants
    Papp, K
    Kapp, A
    Ruer-Mulard, M
    Davidson, MJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P65 - P65
  • [36] Efficacy and Safety of EMLA Cream for Pain Control Due to Venipuncture in Infants: A Meta-analysis
    Shahid, Shaneela
    Florez, Ivan D.
    Mbuagbaw, Lawrence
    PEDIATRICS, 2019, 143 (01)
  • [37] Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: An open-label clinical study in Korean patients
    Kim, Byung-Soo
    Kim, Su-Han
    Kim, Moon-Bum
    Oh, Chang-Keun
    Jang, Ho-Sun
    Kwon, Kyung-Sool
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (05) : 868 - 872
  • [38] Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis
    Aschoff, Roland
    Schwanebeck, Uta
    Brautigam, Matthias
    Meurer, Michael
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (01) : 24 - 29
  • [39] The effects of pimecrolimus cream 1% on key physiology parameters in patients with atopic dermatitis
    Aschoff, R.
    Schwanebeck, U.
    Braeutigam, M.
    Meurer, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S102 - S102
  • [40] Evaluation of skin reactions to pimecrolimus cream 1% in patients allergic to propylene glycol
    Fowler, J
    Lorenz, D
    Parneix-Spake, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P77 - P77
12345